AGRX logo

Agile Therapeutics (AGRX) Accounts Payable

AGRX Annual Accounts Payable

$9.57 M
+$1.84 M+23.79%

31 December 2023

AGRX Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AGRX Quarterly Accounts Payable

$16.54 M
+$3.92 M+31.09%

01 June 2024

AGRX Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AGRX Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+23.8%+168.7%
3 y3 years+147.6%+158.1%
5 y5 years+994.2%+1957.6%

AGRX Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat highat high

Agile Therapeutics Accounts Payable History

DateAnnualQuarterly
June 2024
-
$16.54 M(+31.1%)
Mar 2024
-
$12.62 M(+31.8%)
Dec 2023
$9.57 M(+23.8%)
$9.57 M(+39.2%)
Sept 2023
-
$6.88 M(+11.7%)
June 2023
-
$6.16 M(-40.6%)
Mar 2023
-
$10.36 M(+33.9%)
Dec 2022
$7.73 M(-11.2%)
$7.73 M(+57.6%)
Sept 2022
-
$4.91 M(-59.2%)
June 2022
-
$12.04 M(+26.2%)
Mar 2022
-
$9.54 M(+9.5%)
Dec 2021
$8.71 M(+125.2%)
$8.71 M(+54.6%)
Sept 2021
-
$5.63 M(-12.1%)
June 2021
-
$6.41 M(+7.8%)
Mar 2021
-
$5.94 M(+53.7%)
Dec 2020
$3.87 M(+112.6%)
$3.87 M(-22.9%)
Sept 2020
-
$5.02 M(-2.1%)
June 2020
-
$5.12 M(+152.1%)
Mar 2020
-
$2.03 M(+11.7%)
Dec 2019
$1.82 M(+107.9%)
$1.82 M(+201.7%)
Sept 2019
-
$603.00 K(-25.0%)
June 2019
-
$804.00 K(+14.9%)
Mar 2019
-
$700.00 K(-20.0%)
DateAnnualQuarterly
Dec 2018
$875.00 K(-68.6%)
$875.00 K(+79.3%)
Sept 2018
-
$488.00 K(-54.7%)
June 2018
-
$1.08 M(-47.9%)
Mar 2018
-
$2.07 M(-25.6%)
Dec 2017
$2.78 M(+35.8%)
$2.78 M(-1.4%)
Sept 2017
-
$2.82 M(-5.5%)
June 2017
-
$2.99 M(-6.2%)
Mar 2017
-
$3.18 M(+55.2%)
Dec 2016
$2.05 M(-14.1%)
$2.05 M(-29.0%)
Sept 2016
-
$2.89 M(-4.0%)
June 2016
-
$3.01 M(+4.8%)
Mar 2016
-
$2.87 M(+20.4%)
Dec 2015
$2.39 M(-9.3%)
$2.39 M(-45.1%)
Sept 2015
-
$4.35 M(+63.3%)
June 2015
-
$2.66 M(-19.5%)
Mar 2015
-
$3.31 M(+25.8%)
Dec 2014
$2.63 M(+267.7%)
$2.63 M(-0.9%)
Sept 2014
-
$2.65 M(+14.2%)
June 2014
-
$2.33 M(+224.5%)
Mar 2014
-
$716.80 K(+0.2%)
Dec 2013
$715.50 K(-36.5%)
$715.50 K
Dec 2012
$1.13 M
-

FAQ

  • What is Agile Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Agile Therapeutics?
  • What is Agile Therapeutics annual accounts payable year-on-year change?
  • What is Agile Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Agile Therapeutics?
  • What is Agile Therapeutics quarterly accounts payable year-on-year change?

What is Agile Therapeutics annual accounts payable?

The current annual accounts payable of AGRX is $9.57 M

What is the all time high annual accounts payable for Agile Therapeutics?

Agile Therapeutics all-time high annual accounts payable is $9.57 M

What is Agile Therapeutics annual accounts payable year-on-year change?

Over the past year, AGRX annual accounts payable has changed by +$1.84 M (+23.79%)

What is Agile Therapeutics quarterly accounts payable?

The current quarterly accounts payable of AGRX is $16.54 M

What is the all time high quarterly accounts payable for Agile Therapeutics?

Agile Therapeutics all-time high quarterly accounts payable is $16.54 M

What is Agile Therapeutics quarterly accounts payable year-on-year change?

Over the past year, AGRX quarterly accounts payable has changed by +$10.39 M (+168.73%)